Shanghai Labway Clinical Laboratory Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wai-Hung Tsang
Chief executive officer
CN¥1.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2.7yrs |
| Board average tenure | 1.9yrs |
Recent management updates
Recent updates
Optimistic Investors Push Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) Shares Up 32% But Growth Is Lacking
Feb 17
Is Shanghai Labway Clinical Laboratory (SZSE:301060) Using Too Much Debt?
Dec 19What Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) 50% Share Price Gain Is Not Telling You
Oct 09Calculating The Intrinsic Value Of Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060)
Sep 30Investor Optimism Abounds Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) But Growth Is Lacking
Aug 13Market Cool On Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) Revenues Pushing Shares 36% Lower
Apr 21A Piece Of The Puzzle Missing From Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) 28% Share Price Climb
Mar 07CEO
Wai-Hung Tsang (57 yo)
Mr. Wai-Hung Tsang is Chairman & GM of Shanghai Labway Clinical Laboratory Co. Ltd from August 20, 2015.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.07m | no data | |
| Head of Finance Center & Director | 1.5yrs | CN¥378.80k | no data | |
| Deputy GM & Non-Independent Director | 3.9yrs | CN¥292.20k | 0.0018% CN¥ 77.4k | |
| Deputy General Manager | less than a year | CN¥104.30k | no data | |
| Secretary to the Board of Directors | 7.2yrs | CN¥912.90k | no data | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 301060's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.07m | no data | |
| Head of Finance Center & Director | less than a year | CN¥378.80k | no data | |
| Deputy GM & Non-Independent Director | 3.9yrs | CN¥292.20k | 0.0018% CN¥ 77.4k | |
| Independent Director | 1.9yrs | CN¥100.00k | no data | |
| Non-Independent Director | 10.3yrs | no data | no data | |
| Director | 3.2yrs | no data | no data | |
| Chairman of the Supervisory Board | 3.3yrs | no data | no data | |
| Independent Director | 1.9yrs | CN¥100.00k | no data | |
| Independent Director | 1.9yrs | CN¥100.00k | no data | |
| Non-Employee Supervisor | less than a year | no data | no data | |
| Non-Employee Supervisor | less than a year | no data | no data |
Experienced Board: 301060's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 02:14 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Labway Clinical Laboratory Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.